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Introduction: Safe, effective tight glycemic control (TGC) can improve outcomes, but is difficult to 
achieve consistently. Glycemic level and variability, particularly early in a patient’s stay, are a 
function of variability in insulin sensitivity/resistance resulting from the level and evolution of 
stress response, and are independently associated with mortality.  
 
Objectives: To examine the daily evolution of variability of insulin sensitivity in ICU patients, and 
determine if critically ill diabetic patients display different metabolic levels or variability.  
 
Method: Retrospective analysis of patient data (N=257 patients, 26201hours) from the SPRINT 
TGC study where SPRINT was commenced within 12 hours of ICU admission. Model-based 
insulin sensitivity (SI) was identified each hour and hour-to-hour percent changes in SI were 
assessed for days 1-3 individually and day 4 onward. Diagnosed (T1DM and T2DM) diabetics 
(N=59) are compared to non-diabetic patients (N=198) on both cohort and per-patient bases to 
assess differences in metabolic level or variability. Cumulative distribution functions, median 
values, and 90% range (5th-95th percentiles) are used to assess differences between groups and 
their evolution over time.  
 
Results: In both diabetic and non-diabetic groups, SI increases significantly over the first 24 
hours (p<0.02). For days 2-3, further increases are not clinically or statistically significant. 
However, median insulin sensitivity is 18-42% lower for diabetics compared to non-diabetics over 
days 1-3 and 4 onward (p<0.05). 
 
SI Variability (hour-to-hour percentage change) is higher on day 1 than days 2, 3 and 4 onward 
(p<0.0001) for both diabetic and non-diabetic groups. SI variability decreases during days 2-3, 
but the reduction is much smaller and not clinically or statistically significant. Diabetics are 
significantly more variable than non-diabetics on days 1-3 of ICU stay (p<0.05). 
 
Conclusion: ICU patients have lower insulin sensitivity and are more variable on day 1 of stay 
compared to days 2-3 and 4 onward. Diabetic patients have even lower and more variable SI 
compared to non-diabetics during days 1-3. Greater variability with lower SI early in a patient’s 
stay greatly increases the insulin required, potential glucose flux due to variation in SI, and thus 
the risk of greater glycemic variability and hypoglycemia – all of which reduce potential positive 
outcomes. Clinically, these results suggest that TGC patients, particularly those with a diabetic 
history, will require greater measurement frequency, reduced reliance on insulin, and more 
explicit specification of carbohydrate nutrition in Days 1-3 to safely minimize outcome glycemic 
variability. 
 
 
